Tokyo Tape
Sign in
← Ensuiko Sugar Refining

Quarterly report · Q2

2112.TEDINET S100PGCP
Period2022-04-01 → 2022-09-30
Filed2022-11-04
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥13.4bn2022-04-01 → 2022-09-30Cons.Net sales
Revenue¥25.1bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥12.2bn2021-04-01 → 2021-09-30Cons.Net sales
Operating income¥274m2022-04-01 → 2022-09-30Cons.Operating income
Operating income¥454m2021-04-01 → 2021-09-30Cons.Operating income
Ordinary income¥244m2022-04-01 → 2022-09-30Cons.Ordinary income
Ordinary income¥906m2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥389m2021-04-01 → 2021-09-30Cons.Ordinary income
Profit before tax¥244m2022-04-01 → 2022-09-30Cons.Income before income taxes
Profit before tax¥389m2021-04-01 → 2021-09-30Cons.Income before income taxes
Net income (owners)¥138m2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥609m2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥233m2021-04-01 → 2021-09-30Cons.Profit loss attributable to owners of parent
Net income¥138m2022-04-01 → 2022-09-30Cons.Profit loss
Net income¥233m2021-04-01 → 2021-09-30Cons.Profit loss
Total assets¥25.2bnat 2022-09-30Cons.Assets
Total assets¥26.1bnat 2022-03-31Cons.Assets
Total assets¥26.7bnat 2021-09-30Cons.Total assets (5-year summary)
Total liabilities¥14.8bnat 2022-09-30Cons.Liabilities
Total liabilities¥15.7bnat 2022-03-31Cons.Liabilities
Net assets / equity¥10.4bnat 2022-09-30Cons.Net assets
Net assets / equity¥10.4bnat 2022-03-31Cons.Net assets
Net assets / equity¥10.0bnat 2021-09-30Cons.Net assets (5-year summary)
Cash and deposits¥2.3bnat 2022-09-30Cons.Cash and deposits
Cash and deposits¥3.5bnat 2022-03-31Cons.Cash and deposits
Cash & equivalents¥2.3bnat 2022-09-30Cons.Cash and cash equivalents
Cash & equivalents¥3.5bnat 2022-03-31Cons.Cash and cash equivalents
Cash & equivalents¥3.7bnat 2021-09-30Cons.Cash and cash equivalents
Cash & equivalents¥4.9bnat 2021-03-31dCons.Cash and cash equivalents
Operating cash flow¥104m2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥1.1bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥210m2021-04-01 → 2021-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥172m2022-04-01 → 2022-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥711m2021-04-01 → 2022-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥482m2021-04-01 → 2021-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥1.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥1.7bn2021-04-01 → 2022-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥948m2021-04-01 → 2021-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥5.12022-04-01 → 2022-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-3.142022-07-01 → 2022-09-30dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥22.432021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥8.612021-04-01 → 2021-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-1.552021-07-01 → 2021-09-30dCons.Basic earnings loss per share (5-year summary)
Equity ratio41.2%at 2022-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio39.7%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio37.5%at 2021-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Otherother segmentsrevenue2022-04-01 → 2022-09-30¥67m
Otherother segmentsrevenue external2022-04-01 → 2022-09-30¥59m
Otherother segmentsrevenue intersegment2022-04-01 → 2022-09-30¥8m
Otherother segmentssegment profit2022-04-01 → 2022-09-30¥30m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-09-30−¥55m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-09-30−¥55m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-09-30−¥577m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentrevenue2022-04-01 → 2022-09-30¥925m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentrevenue external2022-04-01 → 2022-09-30¥891m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥34m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentsegment profit2022-04-01 → 2022-09-30¥238m
jpcrp040300-q2r_E00361-000Sugarreportable segmentrevenue2022-04-01 → 2022-09-30¥12.4bn
jpcrp040300-q2r_E00361-000Sugarreportable segmentrevenue external2022-04-01 → 2022-09-30¥12.4bn
jpcrp040300-q2r_E00361-000Sugarreportable segmentrevenue intersegment2022-04-01 → 2022-09-30¥13m
jpcrp040300-q2r_E00361-000Sugarreportable segmentsegment profit2022-04-01 → 2022-09-30¥582m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-09-30¥13.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-09-30¥13.4bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-09-30¥55m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-09-30¥851m
Otherother segmentsrevenue2021-04-01 → 2021-09-30¥66m
Otherother segmentsrevenue external2021-04-01 → 2021-09-30¥58m
Otherother segmentsrevenue intersegment2021-04-01 → 2021-09-30¥8m
Otherother segmentssegment profit2021-04-01 → 2021-09-30¥30m
Reconciling Itemsreconcilingrevenue2021-04-01 → 2021-09-30−¥50m
Reconciling Itemsreconcilingrevenue intersegment2021-04-01 → 2021-09-30−¥50m
Reconciling Itemsreconcilingsegment profit2021-04-01 → 2021-09-30−¥586m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentrevenue2021-04-01 → 2021-09-30¥939m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentrevenue external2021-04-01 → 2021-09-30¥910m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥28m
jpcrp040300-q2r_E00361-000Biotechnologyreportable segmentsegment profit2021-04-01 → 2021-09-30¥264m
jpcrp040300-q2r_E00361-000Sugarreportable segmentrevenue2021-04-01 → 2021-09-30¥11.3bn
jpcrp040300-q2r_E00361-000Sugarreportable segmentrevenue external2021-04-01 → 2021-09-30¥11.3bn
jpcrp040300-q2r_E00361-000Sugarreportable segmentrevenue intersegment2021-04-01 → 2021-09-30¥14m
jpcrp040300-q2r_E00361-000Sugarreportable segmentsegment profit2021-04-01 → 2021-09-30¥745m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-09-30¥12.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-09-30¥12.2bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-09-30¥50m
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-09-30¥1.0bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 493
ItemContextValueUnit
Cost of salesPrior1YTDDuration10315000000JPY
Cost of salesCurrentYTDDuration11630000000JPY
Gross profitPrior1YTDDuration1930000000JPY
Gross profitCurrentYTDDuration1753000000JPY
Selling general and administrative expensesPrior1YTDDuration1475000000JPY
Selling general and administrative expensesCurrentYTDDuration1479000000JPY
Operating incomePrior1YTDDuration454000000JPY
Operating incomeCurrentYTDDuration274000000JPY
Interest income noiPrior1YTDDuration13000000JPY
Interest income noiCurrentYTDDuration13000000JPY
Dividends income noiPrior1YTDDuration57000000JPY
Dividends income noiCurrentYTDDuration67000000JPY
Other noiPrior1YTDDuration4000000JPY
Other noiCurrentYTDDuration25000000JPY
Non operating incomePrior1YTDDuration74000000JPY
Non operating incomeCurrentYTDDuration106000000JPY
Interest expenses noePrior1YTDDuration50000000JPY
Interest expenses noeCurrentYTDDuration45000000JPY
Equity in losses of affiliates noePrior1YTDDuration60000000JPY
Equity in losses of affiliates noeCurrentYTDDuration85000000JPY
Commission fee noePrior1YTDDuration27000000JPY
Commission fee noeCurrentYTDDuration3000000JPY
Other noePrior1YTDDuration1000000JPY
Other noeCurrentYTDDuration0JPY
Non operating expensesPrior1YTDDuration140000000JPY
Non operating expensesCurrentYTDDuration135000000JPY
Ordinary incomePrior1YTDDuration389000000JPY
Ordinary incomeCurrentYTDDuration244000000JPY
Income before income taxesPrior1YTDDuration389000000JPY
Income before income taxesCurrentYTDDuration244000000JPY
Income taxes currentPrior1YTDDuration138000000JPY
Income taxes currentCurrentYTDDuration112000000JPY
Income taxes deferredPrior1YTDDuration17000000JPY
Income taxes deferredCurrentYTDDuration-6000000JPY
Income taxesPrior1YTDDuration155000000JPY
Income taxesCurrentYTDDuration105000000JPY
Profit lossPrior1YTDDuration233000000JPY
Profit lossCurrentYTDDuration138000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration233000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration138000000JPY
Profit lossPrior1YTDDuration233000000JPY
Profit lossCurrentYTDDuration138000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration4000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration-17000000JPY
Deferred gains or losses on hedges net of tax ociPrior1YTDDuration-0JPY
Deferred gains or losses on hedges net of tax ociCurrentYTDDuration2000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration3000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-1000000JPY
Share of other comprehensive income of associates accounted for using equity method ociPrior1YTDDuration-1000000JPY
Share of other comprehensive income of associates accounted for using equity method ociCurrentYTDDuration-0JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2022-03-31pass
balance sheet identityconsolidated 2022-09-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2021-04-01/2021-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-09-30pass